Utah Medical Products - 41 Year Stock Price History | UTMD
Historical daily share price chart and data for Utah Medical Products since 1984 adjusted for splits and dividends. The latest closing stock price for Utah Medical Products as of May 16, 2025 is 55.10.
- The all-time high Utah Medical Products stock closing price was 116.50 on November 22, 2021.
- The Utah Medical Products 52-week high stock price is 77.33, which is 40.3% above the current share price.
- The Utah Medical Products 52-week low stock price is 51.26, which is 7% below the current share price.
- The average Utah Medical Products stock price for the last 52 weeks is 63.19.
| Utah Medical Products Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 57.4907 | 61.0226 | 63.8275 | 51.7500 | 55.1000 | -9.88% |
| 2024 | 67.7196 | 81.5512 | 82.2838 | 60.5750 | 61.1419 | -25.69% |
| 2023 | 87.5306 | 94.2394 | 96.6880 | 75.0237 | 82.2741 | -15.10% |
| 2022 | 85.3421 | 92.3840 | 97.9088 | 77.3246 | 96.9097 | 1.87% |
| 2021 | 84.9999 | 77.4795 | 116.5030 | 76.4741 | 95.1333 | 21.97% |
| 2020 | 80.5197 | 97.5234 | 99.1312 | 70.6072 | 77.9977 | -20.87% |
| 2019 | 83.2003 | 76.5029 | 99.8437 | 70.4037 | 98.5648 | 31.46% |
| 2018 | 84.6083 | 70.7492 | 104.0640 | 67.3608 | 74.9777 | 3.24% |
| 2017 | 61.7069 | 62.7455 | 74.9870 | 51.7167 | 72.6227 | 13.59% |
| 2016 | 54.9196 | 50.7163 | 63.9319 | 47.9929 | 63.9319 | 26.32% |
| 2015 | 48.3710 | 49.1330 | 53.4471 | 43.3601 | 50.6125 | -0.71% |
| 2014 | 44.5184 | 43.1233 | 51.0430 | 39.4103 | 50.9751 | 7.04% |
| 2013 | 41.1494 | 31.2847 | 52.5733 | 31.2847 | 47.6222 | 61.81% |
| 2012 | 26.2361 | 21.6531 | 29.5213 | 21.3914 | 29.4315 | 37.48% |
| 2011 | 20.8512 | 20.6468 | 22.6174 | 19.0962 | 21.4073 | 4.09% |
| 2010 | 20.0608 | 21.3180 | 22.3858 | 17.9314 | 20.5664 | -2.74% |
| 2009 | 18.5059 | 16.6664 | 21.4625 | 14.8385 | 21.1450 | 38.43% |
| 2008 | 18.8639 | 19.9195 | 20.7944 | 14.7249 | 15.2747 | -23.63% |
| 2007 | 21.0503 | 21.5877 | 22.7083 | 19.6516 | 20.0003 | -7.30% |
| 2006 | 20.3948 | 19.5340 | 22.4295 | 18.1934 | 21.5746 | 5.78% |
| 2005 | 14.9047 | 13.8080 | 20.3958 | 12.4962 | 20.3958 | 46.00% |
| 2004 | 14.1559 | 15.6632 | 16.5445 | 10.5762 | 13.9697 | -12.28% |
| 2003 | 12.9130 | 11.7641 | 15.9251 | 10.6614 | 15.9251 | 36.86% |
| 2002 | 9.5548 | 8.0418 | 11.7458 | 7.6397 | 11.6362 | 40.34% |
| 2001 | 6.4210 | 4.5692 | 8.3707 | 4.2836 | 8.2915 | 81.47% |
| 2000 | 4.3711 | 3.9219 | 5.1023 | 3.6553 | 4.5692 | 11.11% |
| 1999 | 4.1580 | 4.0361 | 4.8357 | 3.4269 | 4.1123 | 2.86% |
| 1998 | 4.2303 | 4.3788 | 5.3307 | 3.0842 | 3.9980 | -3.67% |
| 1997 | 5.4851 | 8.3007 | 8.3007 | 4.0361 | 4.1503 | -49.07% |
| 1996 | 8.9511 | 11.4991 | 13.2506 | 6.8538 | 8.1484 | -32.49% |
| 1995 | 7.6774 | 5.2546 | 12.5652 | 5.2546 | 12.0703 | 133.09% |
| 1994 | 4.9135 | 4.7976 | 5.9399 | 3.8838 | 5.1784 | 7.94% |
| 1993 | 5.8471 | 7.2118 | 8.6743 | 4.5692 | 4.7976 | -34.84% |
| 1992 | 6.4150 | 9.0777 | 9.8847 | 4.3371 | 7.3631 | -23.96% |
| 1991 | 7.2845 | 4.6397 | 9.6829 | 4.2363 | 9.6829 | 108.70% |
| 1990 | 3.8563 | 4.0346 | 5.5475 | 3.1772 | 4.6397 | 19.48% |
| 1989 | 2.0284 | 1.0720 | 4.3371 | 1.0215 | 3.8833 | 262.25% |
| 1988 | 0.8136 | 0.5677 | 1.0969 | 0.5047 | 1.0720 | 84.83% |
| 1987 | 0.6879 | 0.7439 | 0.8577 | 0.4039 | 0.5800 | -22.03% |
| 1986 | 0.7998 | 1.0843 | 1.1347 | 0.6304 | 0.7439 | -31.39% |
| 1985 | 1.0921 | 0.6685 | 1.4125 | 0.6304 | 1.0843 | 62.20% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.180B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |